Publications

Metallonutraceuticals is totally new area for Pharmaceuticals and Nutritional Industry and can create totally innovative products for entire world.
Handbook of Metallonutraceuticals presents basic concepts related to the nutritional and therapeutic use of metals, product development strategies, and some ideas ready to be applied for condition-specific metallonutraceuticals. The book begins with an overview of the nutraceuticals field and the need for metallonutraceuticals. It considers the roles of various metals in metabolism, reviews the ethnopharmacology and ethnomedicine of metals, and covers the characterization and possible properties of metallonutraceuticals. It also examines bioavailability and drug interactions, and therapeutic applications of nanometals including use as imaging agents, in cancer diagnosis and treatment, as antibacterials and antivirals, in ocular disease, and in neurodegenerative diseases.

The book explores the use of metals in traditional Chinese medicine, potential applications for metalloenzymes, the use of nanosilver in nutraceuticals, and the potential of gold nanoparticles as a drug delivery system. In addition, it addresses intellectual property rights and regulatory considerations regarding metallonutraceuticals. Using an interdisciplinary approach, this user-friendly text provides a knowledge base and inspiration for new research in this exciting field.

• Presents background information on nutraceuticals and the therapeutic use of metals.
• Captures ready-to-go applied research leads in designing new functional foods.
• Proposes quality assurance norms for industry players to bring harmonization and control check points in process and product development in metallonutraceuticals
• Provides a vivid explanation of institutional regulations and ethics for nutraceutical industrial operations and corporate transactions.
• Describes gold nanoparticles and a drug delivery system with therapeutic applications.
• Discusses nanometals for use in dentistry, as a dermal protectant, for diabetes treatment, for cancer diagnostics and therapeutics, and more.

Botanicals, which have been part of human food and medicine for thousands of years, are perceived as being safer than synthetic pharmaceuticals. The global botanical drug market was expected to reach $26.6 billion by 2017. In terms of FDA regulations, botanical drugs are no different from non-botanical products, having to meet the safety and effectiveness standards of a new drug in accordance. This book comprises a complete start-to-end process from drug-idea conception, to drug development process.

• The first of its kind complete Guide for Pharmaceutical Industry in Botanical Drug Product Development, and Marketing.
• It will include at least 200 ready to go Botanical Drug Product development leads.
• Complete IPR Strategy integrated with Drug Launch.
• Complete Drug Approval Regulatory Pathway with various countries.
• Complete enumeration on Scale Up manufacturing strategies.